KEAP1 and neoplasm: -Alanyl-glutamine dipeptide reduces chemotherapy-related side effects-Glutamine antagonist suppress KEAP1-mutant tumors-Inhibition or genetic silencing of glutamine transporters (SLC7A5, SLC1A5) reduces tumor growth and migration-Glutaminase 1 inhibitors treat glutamine-dependent cancers